A decision by Food Standards Australia New Zealand (FSANZ)
clears the way for Blis Technologies' Blis M18 probiotic to
be used in food.
The Dunedin biotechnology company has welcomed the finding by
the FSANZ that the probiotic was not considered to be a novel
food, either in Australia or New Zealand.
That enabled Blis M18 to be used directly in food
applications such as yoghurt and beverages in Australia and
New Zealand, bypassing the demanding and formal ''novel
A novel food was a non-traditional food with no sufficient
history of safe use. Novel food ingredients could be sold in
Australia and New Zealand but only after undergoing a
rigorous risk and safety assessment by
FSANZ researchers and food scientists. Blis M18 was an oral
cavity probiotic and, like its partner product Blis K12, had
an ''exceptional'' safety record, Blis Technologies chief
executive Dr Barry Richardson said.
The FSANZ's decision would now enable the company to discuss
the application of both probiotics with food manufacturers
wanting to help with their consumers' oral health and fight
tooth decay in children, he said.